Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
197.81
+0.51 (0.26%)
At close: Aug 6, 2026, 4:00 PM EDT
200.80
+2.99 (1.51%)
After-hours: Aug 6, 2026, 7:59 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $42.05 billion as of August 6, 2026. Its market cap has increased by 488.10% in one year.
Market Cap
42.05B
Enterprise Value
40.58B
1-Year Change
488.10%
Ranking
Category
Stock Price
$197.81
ChartMarket Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $42.05B, an increase of 2,457.27%. That is a compound annual growth rate of 64.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 42.05B | 173.11% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 76.30B |
| argenx SE | 54.05B |
| BeOne Medicines AG | 37.10B |
| Royalty Pharma | 33.03B |
| Alnylam Pharmaceuticals | 29.46B |
| Insmed | 28.59B |
| Roivant Sciences | 25.19B |
| Incyte | 23.71B |